252 related articles for article (PubMed ID: 28676218)
1. GTF2I mutation frequently occurs in more indolent thymic epithelial tumors and predicts better prognosis.
Feng Y; Lei Y; Wu X; Huang Y; Rao H; Zhang Y; Wang F
Lung Cancer; 2017 Aug; 110():48-52. PubMed ID: 28676218
[TBL] [Abstract][Full Text] [Related]
2. A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors.
Petrini I; Meltzer PS; Kim IK; Lucchi M; Park KS; Fontanini G; Gao J; Zucali PA; Calabrese F; Favaretto A; Rea F; Rodriguez-Canales J; Walker RL; Pineda M; Zhu YJ; Lau C; Killian KJ; Bilke S; Voeller D; Dakshanamurthy S; Wang Y; Giaccone G
Nat Genet; 2014 Aug; 46(8):844-9. PubMed ID: 24974848
[TBL] [Abstract][Full Text] [Related]
3.
Tarrini G; Ciabatti E; Pacini S; Galimberti S; Petrini I
Anticancer Res; 2017 Oct; 37(10):5459-5462. PubMed ID: 28982856
[TBL] [Abstract][Full Text] [Related]
4. The presence of extrathoracic metastasis is more prognostic of survival than Masaoka stage (IVa/IVb) in metastatic thymic epithelial tumor: a retrospective cohort study.
Shin DY; Kim DW; Keam B; Kim TM; Lee SH; Kang CH; Kim YT; Heo DS
Lung Cancer; 2014 Aug; 85(2):320-5. PubMed ID: 24954359
[TBL] [Abstract][Full Text] [Related]
5. Unique correlation between GTF2I mutation and spindle cell morphology in thymomas (type A and AB thymomas).
Wells K; Lamrca A; Papaxoinis G; Wallace A; Quinn AM; Summers Y; Nonaka D
J Clin Pathol; 2023 Jul; 76(7):463-466. PubMed ID: 35039450
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological analysis of thymic malignancies with a consistent retrospective database in a single institution: from Tokyo Metropolitan Cancer Center.
Okuma Y; Hosomi Y; Watanabe K; Yamada Y; Horio H; Maeda Y; Okamura T; Hishima T
BMC Cancer; 2014 May; 14():349. PubMed ID: 24885581
[TBL] [Abstract][Full Text] [Related]
7. The Integrated Genomic Landscape of Thymic Epithelial Tumors.
Radovich M; Pickering CR; Felau I; Ha G; Zhang H; Jo H; Hoadley KA; Anur P; Zhang J; McLellan M; Bowlby R; Matthew T; Danilova L; Hegde AM; Kim J; Leiserson MDM; Sethi G; Lu C; Ryan M; Su X; Cherniack AD; Robertson G; Akbani R; Spellman P; Weinstein JN; Hayes DN; Raphael B; Lichtenberg T; Leraas K; Zenklusen JC; ; Fujimoto J; Scapulatempo-Neto C; Moreira AL; Hwang D; Huang J; Marino M; Korst R; Giaccone G; Gokmen-Polar Y; Badve S; Rajan A; Ströbel P; Girard N; Tsao MS; Marx A; Tsao AS; Loehrer PJ
Cancer Cell; 2018 Feb; 33(2):244-258.e10. PubMed ID: 29438696
[TBL] [Abstract][Full Text] [Related]
8. Thymic epithelial tumors: examining the GTF2I mutation and developing a novel prognostic signature with LncRNA pairs to predict tumor recurrence.
Liu W; Yang HS; Zheng SY; Weng JH; Luo HH; Lei YY; Feng YF
BMC Genomics; 2022 Sep; 23(1):656. PubMed ID: 36114454
[TBL] [Abstract][Full Text] [Related]
9. Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: the Japanese Association for Research on the Thymus Database Study.
Omasa M; Date H; Sozu T; Sato T; Nagai K; Yokoi K; Okamoto T; Ikeda N; Tanaka F; Maniwa Y;
Cancer; 2015 Apr; 121(7):1008-16. PubMed ID: 25565590
[TBL] [Abstract][Full Text] [Related]
10. Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features.
Lee HS; Jang HJ; Shah R; Yoon D; Hamaji M; Wald O; Lee JS; Sugarbaker DJ; Burt BM
Clin Cancer Res; 2017 Aug; 23(16):4855-4864. PubMed ID: 28400429
[No Abstract] [Full Text] [Related]
11. Multicenter institutional experience of surgically resected thymic epithelial tumors (TETs): an observational report on behalf of F.O.N.I.C.A.P. (Forza Operativa Nazionale Interdisciplinare Contro il Cancro del Polmone).
Genestreti G; Ampollini L; Burgio MA; Rolli L; Sanna S; Scarpi E; Monti M; Burgio SL; Giannone L; Santo A; Mezzetti M; Casanova C; Buosi R; Rusca M; Amadori D; Gavelli G
Ann Surg Oncol; 2013 Sep; 20(9):2958-63. PubMed ID: 23709100
[TBL] [Abstract][Full Text] [Related]
12. Discovery and validation of DNA methylation markers for overall survival prognosis in patients with thymic epithelial tumors.
Li S; Yuan Y; Xiao H; Dai J; Ye Y; Zhang Q; Zhang Z; Jiang Y; Luo J; Hu J; Chen C; Wang G
Clin Epigenetics; 2019 Mar; 11(1):38. PubMed ID: 30832724
[TBL] [Abstract][Full Text] [Related]
13. Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs).
Tiseo M; Damato A; Longo L; Barbieri F; Bertolini F; Stefani A; Migaldi M; Gnetti L; Camisa R; Bordi P; Buti S; Rossi G
Lung Cancer; 2017 Feb; 104():24-30. PubMed ID: 28212996
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification.
Park MS; Chung KY; Kim KD; Yang WI; Chung JH; Kim YS; Chang J; Kim JH; Kim SK; Kim SK
Ann Thorac Surg; 2004 Sep; 78(3):992-7; discussion 997-8. PubMed ID: 15337034
[TBL] [Abstract][Full Text] [Related]
15. A Knock-In Mouse Model of Thymoma With the GTF2I L424H Mutation.
He Y; Kim IK; Bian J; Polyzos A; Di Giammartino DC; Zhang YW; Luo J; Hernandez MO; Kedei N; Cam M; Borczuk AC; Lee T; Han Y; Conner EA; Wong M; Tillo DC; Umemura S; Chen V; Ruan L; White JB; Miranda IC; Awasthi PP; Altorki NK; Divakar P; Elemento O; Apostolou E; Giaccone G
J Thorac Oncol; 2022 Dec; 17(12):1375-1386. PubMed ID: 36049655
[TBL] [Abstract][Full Text] [Related]
16. Thymic epithelial tumors: prognostic determinants among clinical, histopathologic, and computed tomography findings.
Moon JW; Lee KS; Shin MH; Kim S; Woo SY; Lee G; Han J; Shim YM; Choi YS
Ann Thorac Surg; 2015 Feb; 99(2):462-70. PubMed ID: 25534526
[TBL] [Abstract][Full Text] [Related]
17. Diffuse high intensity PD-L1 staining in thymic epithelial tumors.
Padda SK; Riess JW; Schwartz EJ; Tian L; Kohrt HE; Neal JW; West RB; Wakelee HA
J Thorac Oncol; 2015 Mar; 10(3):500-8. PubMed ID: 25402569
[TBL] [Abstract][Full Text] [Related]
18. The Prognostic Role of the Number of Involved Structures in Thymic Epithelial Tumors: Results from the ESTS Database.
Chiappetta M; Lococo F; Sassorossi C; Aigner C; Ploenes T; Van Raemdonck D; Vanluyten C; Van Schil P; Agrafiotis AC; Guerrera F; Lyberis P; Casiraghi M; Spiaggiari L; Zisis C; Magou C; Moser B; Bauer J; Thomas PA; Brioude G; Passani S; Zsanto Z; Sperduti I; Margaritora S
Ann Surg Oncol; 2024 Jul; 31(7):4298-4307. PubMed ID: 38530530
[TBL] [Abstract][Full Text] [Related]
19. Elevated CRP levels predict poor outcome and tumor recurrence in patients with thymic epithelial tumors: A pro- and retrospective analysis.
Janik S; Bekos C; Hacker P; Raunegger T; Ghanim B; Einwallner E; Beer L; Klepetko W; Müllauer L; Ankersmit HJ; Moser B
Oncotarget; 2017 Jul; 8(29):47090-47102. PubMed ID: 28514756
[TBL] [Abstract][Full Text] [Related]
20. GTF2I Mutation in Thymomas: Independence From Racial-Ethnic Backgrounds. An Indian/German Comparative Study.
Jain D; Guleria P; Singh V; Parshad R; Kumar S; Gaiser T; Kurz KS; Ott G; Porubsky S; Preissler G; Sauer CG; Schölch S; Ströbel P; Hielscher T; Marx A; Popovic ZV
Pathol Oncol Res; 2021; 27():1609858. PubMed ID: 34497477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
